Research Article
Survival Outcomes among Human Epidermal Growth Factor Receptor 2- (HER2-) Positive Breast Cancer Patients at Kenyatta National Hospital
Table 2
Clinical characteristics of HER2-positive breast cancer patients.
| | Variable | Frequency | Percent |
| | Stage of cancer | | | | Stage I | 1 | 2.0 | | Stage II | 17 | 34.0 | | Stage III | 14 | 28.0 | | Stage IV | 18 | 36.0 | | Comorbidity | | | | Present | 22 | 44.0 | | Absent | 28 | 56.0 | | Number of comorbidities | | | | Zero | 28 | 56.0 | | One | 16 | 32.0 | | Two | 6 | 12.0 | | Any distant metastasis | | | | No | 32 | 64.0 | | Yes | 18 | 36.0 | | Type of comorbidity | | | | Diabetes mellitus | 11 | 22 | | Hypertension | 7 | 14 | | Retroviral disease | 7 | 14 | | Deep vein thrombosis | 2 | 4 | | Anemia | 1 | 2 |
|
|
